S&P 500
(0.00%) 5 469.11 points
Dow Jones
(0.02%) 39 120 points
Nasdaq
(0.29%) 17 769 points
Oil
(-0.26%) $80.62
Gas
(-5.04%) $2.62
Gold
(-0.91%) $2 309.70
Silver
(-0.44%) $28.74
Platinum
(3.07%) $1 016.70
USD/EUR
(0.35%) $0.936
USD/NOK
(0.74%) $10.68
USD/GBP
(0.52%) $0.792
USD/RUB
(-0.28%) $87.25

Sanntidsoppdatering for Infinity Pharmaceuticals [INFI]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert29 sep 2023 @ 21:59

-52.38% $ 0.00800

Live Chart Being Loaded With Signals

Commentary (29 sep 2023 @ 21:59):
Profile picture for Infinity Pharmaceuticals Inc

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors...

Stats
Dagens volum 2.48M
Gjennomsnittsvolum 3.98M
Markedsverdi 726 089
EPS $-0.110 ( Q2 | 2023-08-10 )
Neste inntjeningsdato ( $0 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0182
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00900 (230.77%)
AADI -6.52%
ABCL 0.73%
ABCM 0.04%
ABEO -3.20%
ABIO -0.30%
ABOS 5.14%
ABSI 2.55%
ABUS -0.98%
ABVX -3.00%
ACAD -0.38%
ACER -17.95%
ACET -9.18%
ACGN 1.29%
ACHL -1.70%
ACHV 2.91%
ACIU 0.00%
ACLX -0.63%
ACRV -4.79%
ACST -3.58%
ACXP 3.69%
ADAG 7.14%
ADAP -4.01%
ADGI 0.87%
ADIL -3.65%
ADMA -1.27%
ADPT 0.12%
ADTX -3.47%
ADVM 0.72%
ADXN -1.60%
AEON -4.67%
AEZS -2.49%
AFMD -2.98%
AGEN -3.80%
AGIO -2.64%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 8.08%
AKRO -2.70%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC -0.57%
ALGS -3.00%
ALKS 1.72%
ALLK -11.44%
ALLO -4.17%
ALLR -1.49%
ALNA 3.16%
ALNY 2.28%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -15.94%
ALVR -1.00%
ALXN 0.00%
ALXO -11.43%
ALZN 5.10%
AMRN -2.79%
AMTI -3.13%
ANAB 1.05%
ANEB 7.95%
ANGN 0.00%
ANIX -3.64%
ANL -0.14%
ANNX 3.93%
ANPC -3.15%
APGE 1.56%
APGN 8.48%
APGNW 30.65%
APLM -5.86%
APLS 0.16%
APLT 0.90%
APM 1.26%
APOP 0.38%
APRE -3.13%
APTO 0.62%
APTX 3.17%
APVO 0.38%
ARAV -13.39%
ARCT -6.70%
ARDS -12.13%
ARDX 1.66%
ARGX -0.57%
ARNA 0.00%
ARPO -0.90%
ARQT -2.14%
ARTL -2.50%
ARTLW 0.00%
ARVN 7.28%
ARWR -2.42%
ASLN -4.68%
ASMB -5.58%
ASND -2.42%
ATAI -3.33%
ATHA 6.85%
ATHE 0.08%
ATHX -33.50%
ATNF 2.18%
ATOS 4.83%
ATRA -5.46%
ATXI 2.68%
ATXS -0.78%
AUPH -0.99%
AURA 4.55%
AUTL -3.45%
AVBP -4.46%
AVEO 0.00%
AVIR -1.75%
AVRO -1.41%
AVTE -1.03%
AVTX -3.67%
AVXL -5.67%
AXLA 0.00%
AXSM -1.22%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.24%
BCAB -6.54%
BCDA -0.85%
BCDAW -41.77%
BCEL 0.00%
BCLI 2.07%
BCRX 1.81%
BCTX 12.24%
BCTXW 13.02%
BCYC 0.90%
BDRX -2.98%
BDTX 1.07%
BEAM 2.85%
BFRA -2.91%
BGNE -2.97%
BIOR -5.80%
BIVI 1.71%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.63%
BLTE -1.44%
BLU 0.03%
BLUE -4.89%
BMEA -16.03%
BMRN 0.26%
BNOX 4.46%
BNTC -3.06%
BNTX -1.55%
BOLD -11.17%
BOLT -0.19%
BPMC -2.26%
BPTH -4.05%
BPTS -13.47%
BRNS -0.37%
BRTX -3.77%
BTAI 14.83%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 1.70%
CABA 0.55%
CADL 0.71%
CALA 0.00%
CALC -10.43%
CALT -1.59%
CAPR 0.00%
CARA -11.44%
CARM 7.39%
CASI 3.86%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.22%
CCCC -2.23%
CCXI 0.00%
CDAK 0.00%
CDIO -4.74%
CDIOW 24.00%
CDMO -1.41%
CDMOP 0.04%
CDT -4.88%
CDTTW -39.60%
CDTX -6.28%
CDXC 9.22%
CDXS 9.66%
CELC -3.64%
CELU 0.74%
CELUW 11.80%
CERC -1.68%
CERE -1.48%
CERO -3.42%
CEROW -10.18%
CFRX -27.95%
CGEM -0.67%
CGEN -3.59%
CGON -2.99%
CGTX -3.98%
CHMA -6.00%
CHRS 4.73%
CINC 0.00%
CING -1.37%
CINGW 34.95%
CKPT -0.96%
CLBS -16.75%
CLDX -0.64%
CLGN -0.60%
CLLS -3.11%
CLNN -1.39%
CLNNW 0.00%
CLRB 5.90%
CLSD -2.53%
CLSN -0.68%
CLVS 0.00%
CMMB -3.89%
CMND 4.84%
CMPI 0.00%
CMPX 1.89%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.55%
CNCE 0.00%
CNSP -33.10%
CNST 0.00%
CNTA 0.28%
CNTB -1.50%
CNTX -5.02%
COCP -2.40%
COEPW 32.45%
COGT -2.82%
CORT 3.39%
COYA 0.49%
CPRX -1.68%
CRBP -2.10%
CRBU -7.95%
CRDF 2.21%
CRGX -0.37%
CRIS -2.64%
CRNX -5.86%
CRSP 1.11%
CRTX 2.63%
CRVO -3.03%
CRVS 0.28%
CSBR -0.20%
CTCX 1.20%
CTIC 0.06%
CTMX -4.56%
CTNM 3.69%
CTXR -4.48%
CUE -2.42%
CVAC -5.92%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 19.49%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.55%
CYTO 0.00%
DARE 0.86%
DAWN -0.30%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 28.76%
DNLI -2.10%
DNTH -3.05%
DOMH 1.06%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW -0.04%
DRUG -0.10%
DSGN -2.57%
DTIL -0.21%
DYAI 9.68%
EARS -1.77%
EDIT -3.22%
EDSA 4.14%
EFTR 2.70%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 7.56%
ELEV -2.28%
ELOX 10.77%
ELTX -3.38%
ELVN 0.00%
ELYM 5.30%
ENGN 0.49%
ENGNW -21.67%
ENLV -1.45%
ENOB 1.79%
ENSC 6.55%
ENTA -1.06%
ENTO -4.97%
ENTX 0.54%
ENVB -0.02%
EPIX -2.68%
EPRX -2.30%
EPZM 0.00%
EQ -1.24%
EQRX -2.09%
EQRXW 0.00%
ERAS 4.82%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -6.17%
ETON 2.59%
ETTX 0.00%
EVAX -2.14%
EVGN 2.77%
EVLO 0.00%
EWTX -0.17%
EXAI -0.57%
EXEL 0.56%
EYEG -0.69%
EYEN 0.02%
EYPT 0.00%
FATE -12.23%
FBIO 1.20%
FBIOP 0.87%
FBLG -10.70%
FBRX -0.02%
FDMT -4.98%
FENC -2.58%
FGEN -9.83%
FHTX 9.35%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.77%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.89%
FULC 2.93%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -1.35%
GANX -0.84%
GBIO -1.59%
GBT 0.01%
GDTC 0.50%
GERN -1.44%
GHRS -4.31%
GLMD -3.02%
GLPG -1.85%
GLSI 9.23%
GLTO -3.90%
GLUE -2.37%
GLYC -14.59%
GMAB -0.35%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -5.03%
GNPX -4.41%
GNTA 3.94%
GOSS -8.76%
GOVX -5.45%
GOVXW 10.89%
GPCR -7.13%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -2.13%
GRTX -1.66%
GTHX 3.64%
GUTS -0.23%
GXGXW 41.67%
GYRE -6.30%
HALO -1.18%
HARP 0.09%
HCWB -10.05%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX -1.15%
HOOK 2.03%
HOTH -0.82%
HOWL 0.64%
HRMY 2.23%
HRTX 8.52%
HSTO 0.00%
HUMA 1.12%
HUMAW -6.25%
IBRX -6.54%
ICCC -2.10%
ICPT 0.21%
ICU 18.48%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.29%
IFRX -3.08%
IGMS -1.90%
IKNA -0.89%
IKT 0.00%
IMAB -0.29%
IMCR -3.56%
IMGN 0.02%
IMGO 0.00%
IMMP 5.73%
IMMX -5.19%
IMNM 3.99%
IMNN 1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -4.18%
IMTX -1.17%
IMTXW 6.00%
IMUX -1.85%
IMV 0.00%
IMVT -3.77%
INAB -1.68%
INBX -2.98%
INCY -1.97%
INDP 6.88%
INFI -52.38%
INKT -0.46%
INM 3.18%
INMB 3.78%
INO 2.34%
INSM -0.91%
INTS -3.73%
INVA 0.62%
INZY 1.49%
IOBT -7.09%
IONS 1.20%
IOVA -4.08%
IPA 3.00%
IPHA 5.08%
IPSC -2.34%
IRON -2.04%
ISEE 0.38%
ITOS 2.60%
ITRM 1.52%
IVA 6.96%
IVVD 0.00%
JAGX 0.52%
JANX -4.78%
JAZZ -1.00%
JNCE 0.00%
JSPR -2.11%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -2.47%
KALV -2.56%
KDNY 0.22%
KMPH -0.34%
KNSA -2.32%
KNTE -0.38%
KOD -8.89%
KPRX -5.76%
KPTI -8.85%
KRBP -10.00%
KRON 1.61%
KROS -0.46%
KRRO -2.12%
KRTX 0.03%
KRYS 0.69%
KTRA 10.32%
KTTA -0.65%
KTTAW 0.92%
KURA 0.59%
KYMR -3.44%
KYTX -5.17%
KZIA 7.51%
KZR -1.72%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 2.64%
LENZ -3.17%
LEXX -0.77%
LEXXW -14.63%
LGND -0.75%
LGNDV 0.00%
LGVN -9.84%
LIAN -8.28%
LIFE 2.70%
LIPO -5.29%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -4.36%
LPTX -2.75%
LQDA 0.49%
LRMR -1.71%
LSTA -1.68%
LTRN 5.74%
LUMO 0.67%
LVTX -4.59%
LXEO -11.50%
LXRX -2.06%
LYEL -35.54%
LYRA 4.22%
MACK 0.10%
MBIO -9.56%
MBRX -1.43%
MCRB 1.60%
MDGL -1.91%
MDNA -13.16%
MDWD 3.18%
MDXG -1.69%
MEIP 0.70%
MESO -1.63%
MGNX -5.59%
MGTA -7.74%
MGTX -0.95%
MGX -0.54%
MIRM -0.57%
MIRO 0.59%
MIST 2.48%
MITO 0.00%
MLEC -6.54%
MLECW 2.31%
MLND -5.36%
MLTX 0.67%
MLYS -7.48%
MNKD -0.86%
MNMD 3.15%
MNOV 1.41%
MNPR -8.59%
MOLN 0.76%
MOR 0.62%
MORF -3.09%
MREO 0.14%
MRKR -0.43%
MRNA -10.48%
MRNS -6.25%
MRSN -4.05%
MRTX -0.17%
MRUS 0.37%
MRVI 0.73%
MTCR -1.29%
MTEM 7.67%
MTP -18.50%
MURA -3.87%
MYMD 1.08%
NAMS -0.33%
NAMSW 0.64%
NAUT 0.66%
NBRV 0.71%
NBSE -1.56%
NBTX 8.91%
NCNA -0.18%
NERV -1.58%
NEXI -0.74%
NGM -1.28%
NGNE 4.50%
NKGN 10.92%
NKGNW -20.00%
NKTR 1.40%
NKTX -2.28%
NLSP 2.88%
NLSPW 26.67%
NMRA -0.97%
NMTR -42.97%
NOVN -24.84%
NRBO 15.02%
NRIX -1.25%
NRSN 0.80%
NRSNW 0.00%
NRXP -7.43%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.63%
NTEC -12.45%
NTHI 0.00%
NTLA -4.71%
NTRBW -31.07%
NUVL -1.84%
NVAX -5.86%
NVCT -7.61%
NVIV -34.28%
NXTC -5.29%
NYMX -0.05%
OABI 3.30%
OABIW -10.06%
OBIO 1.46%
OBSV 0.00%
OCEA -3.65%
OCGN 7.20%
OCS -1.00%
OCUL 0.69%
OCUP 0.00%
ODT -4.27%
OKYO 1.72%
OLMA -4.69%
OMER -2.31%
OMGA -2.08%
ONCO 5.46%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 2.49%
ONTX -0.47%
ONVO 3.72%
OPNT 0.00%
OPT -5.15%
ORGS -0.69%
ORIC -2.67%
ORMP 16.33%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.83%
OVID 0.00%
OYST 0.00%
PALI -0.48%
PASG 0.88%
PBLA -7.50%
PBM -3.44%
PBYI 3.89%
PCSA 0.00%
PCVX 1.07%
PDSB -6.33%
PEPG 1.37%
PGEN -6.29%
PHAR 1.99%
PHAS 0.00%
PHAT 0.00%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.60%
PHXM -5.20%
PIRS -1.64%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.84%
PLUR 10.75%
PMN -5.55%
PMVP -2.08%
PNT 0.16%
PPBT -2.98%
PRAX 5.12%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 0.67%
PRQR 0.60%
PRTA -3.03%
PRTC 0.49%
PRTG 1.40%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.20%
PSTX -4.26%
PTCT -0.78%
PTE -0.82%
PTGX 0.22%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.25%
QLGN -5.56%
QNCX 1.93%
QNRX 0.87%
QSI -30.38%
QSIAW -9.44%
QTTB 2.91%
QURE -1.35%
RAIN -1.63%
RANI 4.28%
RAPT -2.11%
RARE 2.03%
RCKT -10.10%
REGN -0.21%
RENB -4.02%
REPL -3.06%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 5.00%
RGLS -5.61%
RGNX -6.25%
RIGL -6.24%
RLAY -5.65%
RLMD 0.33%
RLYB -4.71%
RNA 2.16%
RNAC -2.60%
RNAZ -1.89%
RNXT 2.23%
ROIV -2.17%
ROIVW 4.56%
RPHM -2.17%
RPRX -0.91%
RPTX -1.32%
RUBY 2.70%
RVLP -32.05%
RVMD -0.44%
RVMDW -29.90%
RVNC 0.21%
RVPH -0.40%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.07%
RYTM -6.08%
RYZB 0.02%
RZLT 2.84%
SABS -1.37%
SABSW -5.53%
SAGE -0.73%
SANA -2.21%
SAVA -3.53%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 1.62%
SCPH 10.86%
SCPS 0.00%
SEEL -4.78%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -4.80%
SGMT -5.07%
SGTX -2.56%
SIOX 22.63%
SLDB -3.28%
SLGL 5.23%
SLN -8.28%
SLNO 0.72%
SLRX -0.81%
SLS -3.41%
SMMT -3.37%
SNDX 1.97%
SNGX 3.40%
SNPX -0.69%
SONN 0.54%
SPPI -0.49%
SPRB -1.68%
SPRC -3.29%
SPRO 0.75%
SRNE 0.00%
SRPT -0.91%
SRRA 0.00%
SRRK -1.55%
SRZN -2.45%
STAB 0.00%
STOK -6.95%
STRO -3.18%
STSA 0.00%
STTK 6.61%
SURF -0.93%
SVRA -4.20%
SWTX -0.52%
SYBX 0.00%
SYRS -1.98%
TALS -0.73%
TARA -10.45%
TARS -2.32%
TBPH 0.00%
TCBP 5.49%
TCDA 0.00%
TCON -0.70%
TCRR 0.00%
TCRT 4.59%
TCRX -0.81%
TECH -1.53%
TENX -0.32%
TERN -7.00%
TFFP -12.18%
TGTX -7.87%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.53%
TNGX -3.46%
TNXP -10.00%
TNYA -4.73%
TPST 5.58%
TRDA -5.01%
TRVI 1.92%
TRVN 3.19%
TSHA -18.70%
TSVT -3.99%
TTNP -6.05%
TVTX 3.64%
TYRA -7.13%
UBX -2.13%
UNCY -4.00%
URGN 3.09%
UTHR -0.34%
VACC 11.36%
VALN -2.96%
VAXX 126.67%
VBIV -1.14%
VBLT -8.77%
VCEL 1.52%
VCNX 8.64%
VCYT -1.01%
VERA -3.99%
VERU 1.30%
VERV -3.54%
VIGL -0.27%
VINC 2.81%
VIR -1.08%
VIRI -5.66%
VIRX 3.85%
VKTX -1.68%
VLON -13.04%
VNDA -3.09%
VOR -6.07%
VRCA 1.69%
VRDN -3.49%
VRNA -2.13%
VRPX 3.73%
VRTX -0.06%
VSTM 4.74%
VTGN -2.11%
VTVT 1.28%
VTYX -1.46%
VXRT -1.32%
VYGR -0.77%
VYNE -5.80%
VYNT 7.78%
WINT -2.72%
WVE -8.49%
XBIO 1.03%
XBIT 6.29%
XCUR 0.23%
XENE -0.72%
XERS 5.48%
XFOR 6.25%
XLO 3.32%
XLRN 0.00%
XNCR -0.05%
XOMA -8.41%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.76%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.81%
ZNTL -1.31%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-09-09 Perkins Adelene Q Buy 768 133 Common Stock
2023-09-12 Perkins Adelene Q Sell 410 196 Common Stock
2023-09-09 Perkins Adelene Q Sell 768 133 Restricted Stock Unit
2022-08-02 Peluso Stephane Buy 14 994 Common Stock
2022-08-02 Peluso Stephane Sell 50 000 Restricted Stock Unit
INSIDER POWER
-20.62
Last 96 transactions
Buy: 10 433 668 | Sell: 9 549 867

Volum Korrelasjon

Lang: 0.01 (neutral)
Kort: 0.15 (neutral)
Signal:(27.787) Neutral

Infinity Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
CHNA0.856
10 Mest negative korrelasjoner
HPLT-0.889

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Infinity Pharmaceuticals Korrelasjon - Valuta/Råvare

The country flag -0.53
( weak negative )
The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag -0.42
( neutral )
The country flag 0.00
( neutral )
The country flag 0.84
( strong )

Infinity Pharmaceuticals Økonomi

Annual 2022
Omsetning: $2.59M
Bruttogevinst: $1.03M (39.72 %)
EPS: $-0.480
FY 2022
Omsetning: $2.59M
Bruttogevinst: $1.03M (39.72 %)
EPS: $-0.480
FY 2021
Omsetning: $1.86M
Bruttogevinst: $738 000 (39.72 %)
EPS: $-0.530
FY 2020
Omsetning: $1.72M
Bruttogevinst: $682 000 (39.67 %)
EPS: $-0.680

Financial Reports:

No articles found.

Infinity Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 3.7234590053558 seconds
Number of API calls: 3
Number of DB calls: 9